검색
검색 팝업 닫기

Ex) Article Title, Author, Keywords

Article

Original Articles

Clinical Pain 2022; 21(2): 74-79

Published online December 31, 2022 https://doi.org/10.35827/cp.2022.21.2.74

Copyright © Korean Association of Pain Medicine.

Digital Therapeutics for the Musculoskeletal Disorders

근골격계 질환에서 디지털치료제의 적용

Jinyoung Park, M.D.1 and Jung Hyun Park, M.D., Ph.D.1,2,3,4

박진영1ㆍ박중현1,2,3,4

1Department of Rehabilitation Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 2Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, 3Department of Integrative Medicine, Yonsei University College of Medicine, 4Department of Medical Device Engineering and Management, Yonsei University College of Medicine, Seoul, Korea

연세대학교 의과대학 재활의학교실, 강남세브란스병원 재활의학과1, 연세대학교 의과대학 희귀난치성 신경근육병 재활연구소2, 연세대학교 의과대학 융합의학과3, 연세대학교 의과대학 의료기기산업학과4

Received: November 22, 2022; Revised: December 8, 2022; Accepted: December 12, 2022

Abstract

Digital therapeutics (DTx) is emerging in the field of digital healthcare thanks to the development of ICT (information and communications technology), sensors, and AI (artificial intelligence) technology. A clinical trial-based design and manufacturing process is required for DTx before it can be prescribed in the medical field. The risks, and effectiveness and intended use of DTx must then be approved by regulatory authorities. The digital healthcare apps for musculoskeletal disorders, which had previously concentrated on monitoring and feedback on aerobic exercise, have lately begun to be applied to rehabilitative exercises utilizing AI technologies using convolutional neural networks. The development of DTx focusing on therapeutic rehabilitative exercise is expected in the future.

KeywordsDigital therapeutics, Musculoskeletal disorders, Exercise

Korean Association of Pain Medicine

Vol.23 No.1
June 2024

eISSN: 2765-5156

Frequency: Semi Annual

Current Issue   |   Archives

Stats or Metrics

Share this article on :

  • line